Invasive intraductal papillary-mucinous neoplasm of the pancreas: Comparison with pancreatic ductal adenocarcinoma

Journal of Surgical Oncology

Volumn 100, Issue 1, 2009, Pages 13-18

  Murakami, Yoshiaki ^a   Uemura, Kenichiro ^a   Sudo, Takeshi ^a   Hayashidani, Yasuo ^a   Hashimoto, Yasushi ^a   Nakashima, Akira ^a   Sueda, Taijiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Clinicopathological features; Invasive intraductal papillary mucinous neoplasm of the pancreas; Pancreatic ductal adenocarcinoma; Survival

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MEDICAL RECORD; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; SPLENIC VEIN; ADENOCARCINOMA; CANCER INVASION; COLLOID CARCINOMA; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PAPILLARY CARCINOMA; PATHOLOGY; SURVIVAL RATE;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; SURVIVAL RATE;

EID: 67649406252     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21290     Document Type: Article

References (32)

1. Tanaka M, Chari S, Adsay V, et al.: International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
2. Murakami Y, Uemura K, Ohge H, et al.: Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Surgery 2006; 140:448-453. (Pubitemid 44247038)
3. Klöppel G, Solcia E, Longnecker DS, et al.: Histological typing of tumours of the exocrine pancreas. In: Klöppel G, Solica F, editors. World Health Organization International Histological Classification of Tumours, 2nd edition. Berlin: Springer-Verlag; 1996. pp. 12-19.
4. Solcia E, Capella C, Klöppel G: Tumors of the Pancreas. In: Rosai J, Sobin LH, editors. Atlas of Tumor Pathology, 3rd series. Washington, DC: Armed Forces of Pathology; 1997. pp. 53-64.
5. Schmidt CM, White PB, Waters JA, et al.: Intraductal papillary mucinous neoplasms: Predictors of malignant and invasive pathology. Ann Surg 2007;246:644-654. (Pubitemid 47480616)
6. Falconi M, Salvia R, Bassi C, et al.: Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 2001;88:376-381. (Pubitemid 32238699)
7. Yang AD, Melstrom LG, Bentrem DJ, et al.: Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: An institutional experience. Surgery 2007;142:529-534. (Pubitemid 47575585)
8. Kim SC, Park KT, Lee YJ, et al.: Intraductal papillary mucinous neoplasm of the pancreas: Clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepatobiliary Pancreat Surg 2008;15:183-188.
9. Cuillerier E, Cellier C, Palazzo L, et al.: Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000;95:441-445. (Pubitemid 30106173)
10. D'Angelica M, Brennan MF, Suriawinata AA, et al.: Intraductal papillary mucinous neoplasms of the pancreas: An analysis of clinicopathologic features and outcome. Ann Surg 2004;239: 400-408. (Pubitemid 38229071)
11. Jang JY, Kim SW, Ahn YJ, et al.: Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: Is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005;12:124-132.
12. Sohn TA, Yeo CJ, Cameron JL, et al.: Intraductal papillary mucinous neoplasms of the pancreas: An updated experience. Ann Surg 2004;239:788-799. (Pubitemid 38669430)
13. Seki M, Yanagisawa A, Ohta H, et al.: Surgical treatment of intraductal papillary-mucinous tumor (IPMT) of the pancreas: Operative indications based on surgico-pathologic study focusing on invasive carcinoma derived from IPMT. J Hepatobiliary Pancreat Surg 2003;10:147-155. (Pubitemid 37160940)
14. Nakagohri T, Kinoshita T, Konishi M, et al.: Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol 2007;14:3174-3180. (Pubitemid 47594293)
15. Raut CP, Cleary KR, Staerkel GA, et al.: Intraductal papillary mucinous neoplasms of the pancreas: Effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 2006;13:582-594.
16. Murakami Y, Uemura K, Hayashidani Y, et al.: Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastrointest Surg 2007;11:338-344.
17. Wada K, Kozarek RA, Traverso LW: Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg 2005;189: 632-636. (Pubitemid 40602958)
18. Nagai K, Doi R, Kida A, et al.: Intraductal papillary mucinous neoplasms of the pancreas: Clinicopathologic characteristics and long-term follow-up after resection. World J Surg 2008;32:271-278.
19. Sohn TA, Yeo CJ, Cameron JL, et al.: Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity. Ann Surg 2001;234:313-321. (Pubitemid 32847068)
20. Maire F, Hammel P, Terris B, et al.: Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002;51:717-722.
21. Shimada K, Sakamoto Y, Sano T, et al.: Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: A clinicopathologic comparison with a common type of invasive ductal carcinoma. Pancreas 2006;32:281-287. (Pubitemid 43753970)
22. Woo SM, Ryu JK, Lee SH, et al.: Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: Comparison with pancreatic ductal adenocarcinoma. Pancreas 2008;36:50-55.
23. Murakami Y, Uemura K, Sudo T, et al.: Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma. J Gastrointest Surg 2008;12:534-541.
24. Murakami Y, Uemura K, Sudo T, et al.: Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma. Am J Surg 2008;195:757-762. (Pubitemid 351749450)
25. Murakami Y, Uemura K, Sudo T, et al.: Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas. J Gastrointest Surg 2009;13:85-92.
26. International Union Against Cancer (UICC): TNM classification of malignant tumors, 6th edition. New York: Wiley-Liss; 2002.
27. Pedrazzoli S, DiCarlo V, Dionigi R, et al.: Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998;228:508-517. (Pubitemid 30194394)
28. Yeo CJ, Cameron JL, Lillemoe KD, et al.: Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: Randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002;236:355-368. (Pubitemid 34971345)
29. Farnell MB, Pearson RK, Sarr MG, et al.: A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005;138: 618-630. (Pubitemid 41546183)
30. Oettle H, Post S, Neuhaus P, et al.: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. J Am Med Assoc 2007;297:267-277. (Pubitemid 46143304)
31. Picozzi VJ, Kozarek RA, Traverso LW: Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 2003;185:476-480. (Pubitemid 36513960)
32. Linehan DC, Tan MC, Strasberg SM, et al.: Adjuvant interferonbased chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: A single-institution phase II study. Ann Surg 2008;248:145-151.